admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

How Can We Apply Harm Reduction to HPPD?

Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London...

Green Market Report – Are Psychedelics Leaving Minorities Behind?

MINDCURE Provides Update on Strategic Review

Nova Mentis Announces Closing of Non-Brokered Financing

Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and...

PT301 – Kabir Ali – Addiction, Ketamine, and the Overlooked Gift...

1...152153154...218 Page 153 of 218

Pα+ Psychedelic Bulletin #197: Portuguese Health-Related Professions Unite on Psychedelics; Shrooms,...

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin